Enveric Biosciences, Inc. Profile Avatar - Palmy Investing

Enveric Biosciences, Inc.

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related di…

Biotechnology
US, Naples [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Enveric Biosciences, Inc. has no acquisition track records yet.

M&A Deals · History

Enveric Biosciences, Inc. has no acquisition track records yet.

End of ENVB's Analysis
CIK: 890821 CUSIP: 29405E208 ISIN: US29405E2081 LEI: - UEI: -
Secondary Listings
ENVB has no secondary listings inside our databases.